Ylanan, Marianne Trexie L.
HRN: 20-08-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 750MG (VIAL)
07/23/2022
07/30/2022
IVT
315 Mg
8 Hrs
PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes